Medicine & Life Sciences
lipoprotein-associated coagulation inhibitor
100%
Thromboplastin
54%
Factor VIIa
49%
Factor Xa
35%
alpha-ketothiazole
28%
Pyridines
22%
Platelet Aggregation
16%
Glutamic Acid
15%
Polymers
14%
Thrombin
13%
Complementary DNA
10%
Platelet-Rich Plasma
9%
Anacardic Acids
9%
Hemorrhage
8%
pyridine
8%
Pharmacokinetics
7%
Pentanoic Acids
7%
plasma protein Z
7%
Thrombosis
7%
Factor V
6%
Protein Isoforms
6%
piperidine
5%
Pyrimidines
5%
Hemostasis
5%
Biological Availability
5%
Chromosomes, Human, Pair 2
5%
Drug Design
5%
Glycosylphosphatidylinositols
5%
Coronavirus
5%
Nucleic Acid Repetitive Sequences
5%
Proteins
5%
Chemical Compounds
Blood Clotting Inhibitor
38%
Pathway Inhibitor
34%
Antagonist
15%
Coagulation
13%
Plasma
11%
Thrombin
11%
Complementary DNA
10%
Pharmacokinetics
9%
Bioavailability
8%
Anacardic Acid
6%
Thrombotic
6%
Crystal Structure
6%
Purification
6%
Peptide Hydrolase Inhibitor
6%
Lipoprotein
5%
DNA Sequencing
5%
Phosphatidylinositol
5%